SecBot SecBot
SECBOTREPLAY Home › Report › TWST

TWST · Twist Bioscience CEO Emily Leproust sold $14.2M in stock on Aug 10,…

Twist Bioscience Corp · CLUSTER filed Aug 12, 2026 at 16:05 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Aug 12, 2026 at 16:05 ET

Twist Bioscience CEO Emily Leproust sold $14.2M in stock on Aug 10, 2026, following the company's strong Q3 earnings beat and raised guidance reported on Aug 3. The CEO's sale was part of a cashless exercise of 113,318 options at $26.66, with shares sold at $125.16 to cover taxes and realize gains. Director Robert Chess also sold $2.04M in a similar cashless exercise. Total insider selling of $18.14M represents 0.22% of the $8.2B market cap, which is modest in proportion. The cluster is dominated by option-exercise-related sales, not open-market liquidation of accumulated shares, reducing the bearish signal. The strong earnings beat and raised guidance provide a bullish fundamental backdrop that likely catalyzed these routine post-earnings sales.

  • CEO Leproust sold 113,318 shares at $125.16 for $14.18M on Aug 10, 2026
  • CEO's sale was part of a cashless exercise of options at $26.66 per share
  • Director Chess sold 18,417 shares at $110.89 for $2.04M on Aug 7, 2026
  • Total insider selling of $18.14M equals 0.22% of $8.2B market cap

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access